ScreenerHero
RHKRHÖN-KLINIKUM Aktiengesellschaft
XETRA · DE · Consumer Cyclical · Medical Care Facilities · rhoen-klinikum-ag.com
14.80EUR+0.68%Mkt Cap: 1.07B $P/E: 22.97

RHÖN-KLINIKUM Aktiengesellschaft, together with its subsidiaries, provides in-patient, semi-patient, and outpatient healthcare services in Germany. The company operates acute hospitals, medical care centers, and rehabili…

Industry Peers

Medical Care Facilities
Screen all
HCA
HCA Healthcare, Inc.
$90.30BUSDP/E 13.7
FRE
Fresenius SE & Co. KGaA Inhaber-Aktien o.N.
$28.29BUSDP/E 16.7
THC
Tenet Healthcare Corporation
$21.62BUSDP/E 10.4
FME
Fresenius Medical Care AG & Co. KGaA
$11.94BUSDP/E 12.3
EHC
Encompass Health Corporation
$12.01BUSDP/E 20.3
DVA
DaVita Inc.
$11.38BUSDP/E 15.0
ENSG
The Ensign Group, Inc.
$10.64BUSDP/E 28.6
UHS
Universal Health Services, Inc. Class B
$10.16BUSDP/E 7.0
PACS
PACS Group Inc.
$7.01BUSDP/E 25.9
CHE
Chemed Corporation
$7.00BUSDP/E 26.9
LFST
LifeStance Health Group Inc. Common Stock
$4.90BUSDP/E 98.7
CON
Concentra Group Holdings Parent Inc. Common Stock
$4.43BUSDP/E 22.4
MCOV-B
Medicover AB (publ)
$3.49BUSDP/E 39.0
NHC
National HealthCare Corporation
$3.67BUSDP/E 26.3
OPCH
Option Care Health, Inc.
$3.50BUSDP/E 17.7
BKD
Brookdale Senior Living Inc.
$2.89BUSD
AVAH
Aveanna Healthcare Holdings Inc.
$2.87BUSDP/E 10.4
EMEIS
Emeis SA
$2.46BUSD
ACHC
Acadia Healthcare Company, Inc.
$2.55BUSD
GRDN
Guardian Pharmacy Services Inc. Class A Common Stock
$2.41BUSDP/E 36.5

Key Statistics

Company
Market Cap1.07B $
Enterprise Value895.12M $
Revenue (TTM)2.20B $
Gross Profit209.55M $
Net Income (TTM)37.47M $
Revenue/Share32.92 USD
Last Price14.80 EUR
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees19.1K
CountryDE
SectorConsumer Cyclical
IndustryMedical Care Facilities
ISIN—
Valuation
P/E (Trailing)22.97
P/E (Forward)18.48
PEG4.01
EV/EBITDA7.38
EV/Revenue0.41
P/S0.48
P/B0.74
EPS (TTM)0.64
EPS (Forward)0.79
52W Range
11.3080% of range15.70
52W High15.70 EUR
52W Low11.30 EUR
Profitability
Gross Margin11.31%
Oper. Margin2.35%
EBITDA Margin5.51%
Profit Margin2.02%
ROE2.61%
ROA1.89%
Growth
Revenue Growth5.00%
Earnings Growth40.00%
Cash Flow & Leverage
Operating CF62.17M $
CapEx (TTM)107.72M $
FCF Margin-3.11%
FCF Yield-6.42%
Net Debt-207.50M $
Net Debt/EBITDA-1.71
Balance Sheet
Debt/Equity0.09
Current Ratio2.63
Quick Ratio2.36
Book Value/Sh19.86 EUR
Cash/Share4.673 EUR
Dividends
Fwd Div Rate0.2000 EUR
Trail. Div Rate0.2000 EUR
Div. Yield1.36%
5Y Avg Yield1.94%
Payout Ratio31.25%
Ex-Div DateMay 28, 2026
Pay Date—
Splits
Last Split2:1
Split DateJul 13, 2007
Analyst Consensus
Rating—
Target (Mean)12.50 EUR
Upside (mean)-15.5%
Target Range12.50 EUR – 12.50 EUR
# Analysts1
Ownership
Shares Out.66.94M
Float3.65M
Insiders0.00%
Institutions0.51%
Technical
SMA 5013.39 (+10.5%)
SMA 20012.85 (+15.2%)
Beta0.00
S&P 52W Chg18.16%
Avg Vol (30d)7.99K
Avg Vol (10d)16.34K
Technical Indicators
RSI (14)66.1
MACD0.4839
MACD Signal0.3685
MACD Hist.+0.1155
BB Upper15.75 EUR
BB Middle13.72 EUR
BB Lower11.70 EUR
BB Width29.55%
ATR (14)0.3860 EUR
Vol Ratio (20d)0.31x